This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, United Kingdom, United States
The drug IMLYGIC contains one active pharmaceutical ingredient (API):
|
1
Talimogene laherparepvec
UNII 07730V90L6 - TALIMOGENE LAHERPAREPVEC
|
|
Talimogene laherparepvec is an oncolytic immunotherapy that is derived from HSV-1. Talimogene laherparepvec has been modified to replicate within tumours and to produce the immune stimulatory protein human GM-CSF. Talimogene laherparepvec causes the death of tumour cells and the release of tumour-derived antigens. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| IMLYGIC Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01XL02 | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XL Antineoplastic cell and gene therapy | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1708590, 1708602 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 050826, 475527 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 65763328, 67792809 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 348715, 348717 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8509, 8510 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 044653018, 044653020 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1079249, 1079250 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 130346, 130354 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100362830, 100362846 |
| Country: US | FDA, National Drug Code | Identifier(s): 55513-078, 55513-079 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
